The models were implemented in a user-friendly, research-oriented online prototype, individualized ovarian stimulation guide (InOvaSGuide).<h4>Conclusions</h4>This study introduces an integrated framework for predicting NOR and early-onset moderate-to-severe OHSS risk across different FSH doses. This evidence concerns the gene BRD2 and ovarian hyperstimulation syndrome.